Sinovac Biotech Ltd (SVA) — Tangible Net Worth Ratio
Sinovac Biotech Ltd (SVA) has a Tangible Net Worth Ratio of 99.4% as of June 2024. This metric is calculated by deducting intangible assets ($70.76 Million) from net assets ($11.51 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See SVA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sinovac Biotech Ltd Tangible Net Worth Ratio (1998–2023)
This chart shows how Sinovac Biotech Ltd's Tangible Net Worth Ratio has changed across 23 annual periods from 1998 to 2023. As of June 2024, the ratio stands at 99.4%, reflecting net assets of $11.51 Billion with intangible assets of $70.76 Million USD. See operational self-sufficiency of Sinovac Biotech Ltd to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Sinovac Biotech Ltd (1998–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Sinovac Biotech Ltd from 1998 to 2023, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see SVA stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 99.9% | $12.02 Billion | $8.52 Million | $13.66 Billion | ▲ +0.6 pp |
| 2022 | 99.4% | $12.71 Billion | $79.51 Million | $14.11 Billion | ▼ -0.3 pp |
| 2021 | 99.7% | $13.88 Billion | $41.21 Million | $16.75 Billion | ▲ +0.6 pp |
| 2020 | 99.1% | $1.12 Billion | $9.72 Million | $1.90 Billion | ▲ +1.4 pp |
| 2019 | 97.7% | $352.19 Million | $7.96 Million | $452.30 Million | ▲ +0.6 pp |
| 2018 | 97.2% | $291.93 Million | $8.30 Million | $369.78 Million | ▲ +3.9 pp |
| 2017 | 93.3% | $129.67 Million | $8.70 Million | $211.35 Million | ▲ +0.0 pp |
| 2016 | 93.3% | $129.67 Million | $8.70 Million | $211.35 Million | ▲ +0.3 pp |
| 2015 | 93.0% | $136.50 Million | $9.57 Million | $202.93 Million | ▲ +0.5 pp |
| 2014 | 92.5% | $141.73 Million | $10.61 Million | $238.53 Million | ▲ +0.7 pp |
| 2013 | 91.8% | $143.64 Million | $11.72 Million | $240.69 Million | ▲ +1.2 pp |
| 2012 | 90.7% | $129.44 Million | $12.06 Million | $208.76 Million | ▼ -8.4 pp |
| 2011 | 99.1% | $145.30 Million | $1.34 Million | $215.91 Million | ▼ 0.0 pp |
| 2010 | 99.1% | $147.76 Million | $1.35 Million | $214.36 Million | ▼ -0.1 pp |
| 2009 | 99.2% | $84.47 Million | $695.11K | $145.48 Million | ▲ +1.4 pp |
| 2008 | 97.8% | $53.64 Million | $1.19 Million | $77.44 Million | ▲ +2.0 pp |
| 2007 | 95.8% | $32.90 Million | $1.39 Million | $57.45 Million | ▲ +3.5 pp |
| 2006 | 92.2% | $21.31 Million | $1.65 Million | $37.01 Million | ▲ +6.4 pp |
| 2005 | 85.8% | $16.51 Million | $2.34 Million | $23.37 Million | ▼ -6.3 pp |
| 2004 | 92.1% | $15.56 Million | $1.23 Million | $22.42 Million | ▲ +15.4 pp |
| 2003 | 76.7% | $10.89 Million | $2.54 Million | $14.90 Million | ▲ +2289.6 pp |
| 2002 | -2212.9% | $99.44K | $2.30 Million | $236.25K | ▼ -2312.9 pp |
| 1998 | 100.0% | $29.01K | $0.00 | $33.51K | — |